Cargando…
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database
BACKGROUND: Treatment and outcomes of patients with HER2-positive (HER2+) metastatic breast cancer (MBC) have dramatically improved over the past 20 years. This work evaluated treatment patterns and outcomes according to age. METHODS: Women who initiated a treatment for HER2+ MBC between 2008 and 20...
Autores principales: | Annonay, Mylène, Gauquelin, Lisa, Geiss, Romain, Ung, Mony, Cristol-Dalstein, Laurence, Mouret-Reynier, Marie-Ange, Goncalves, Anthony, Abadie-Lacourtoisie, Sophie, Francois, Eric, Perrin, Christophe, Le Fel, Johan, Lorgis, Véronique, Servent, Véronique, Uwer, Lionel, Jouannaud, Christelle, Leheurteur, Marianne, Joly, Florence, Campion, Loic, Courtinard, Coralie, Villacroux, Olivier, Petit, Thierry, Soubeyran, Pierre, Terret, Catherine, Bellera, Carine, Brain, Etienne, Delaloge, Suzette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503567/ https://www.ncbi.nlm.nih.gov/pubmed/34624756 http://dx.doi.org/10.1016/j.breast.2021.09.011 |
Ejemplares similares
-
Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME)
por: Sirieix, Junien, et al.
Publicado: (2020) -
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program
por: Le Du, Fanny, et al.
Publicado: (2023) -
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort
por: Grinda, T., et al.
Publicado: (2021) -
Impact of body mass index on overall survival in patients with metastatic breast cancer
por: Saleh, Khalil, et al.
Publicado: (2020) -
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
por: Grinda, Thomas, et al.
Publicado: (2021)